World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
10772
World Ranking
3271
National Ranking
281

Danielle M. Gerlag publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Danielle M. Gerlag sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 154 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Danielle M. Gerlag D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Danielle M. Gerlag sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Danielle M. Gerlag is affiliated with UCB Pharma in the United Kingdom and works within the fields of Medicine and Immunology and Microbiology. Their research primarily focuses on Rheumatology, Immunology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, and General Health Professions.

The main topics covered in their work include Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment, T-cell and B-cell Immunology, Autoimmune and Inflammatory Disorders Research, Chronic Lymphocytic Leukemia Research, and Mental Health and Patient Involvement.

Danielle M. Gerlag has authored multiple recent papers, including:

  • Development and formative evaluation of patient research partner involvement in a multi-disciplinary European translational research project, 2020, Research Involvement and Engagement
  • Increased Frequency of CD4+ Follicular Helper T and CD8+ Follicular T Cells in Human Lymph Node Biopsies during the Earliest Stages of Rheumatoid Arthritis, 2022, Cells
  • Synovial gene signatures associated with the development of rheumatoid arthritis in at risk individuals: A prospective study, 2022, Journal of Autoimmunity
  • Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints, 2021, Frontiers in Immunology
  • Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis, 2020, International Journal of Molecular Sciences

Frequent co-authors working alongside Danielle M. Gerlag include Lisa G. M. van Baarsen, Paul P. Tak, Niek de Vries, and J Hähnlein.

Publication venues with multiple works from this researcher include Annals of the Rheumatic Diseases, bioRxiv (Cold Spring Harbor Laboratory), Research Involvement and Engagement, Cells, and the Journal of Autoimmunity.

Best Publications

  • Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis

    Jasper J. Haringman;Danielle M. Gerlag;Aeilko H. Zwinderman;Tom J.M. Smeets

  • EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

    Danielle M. Gerlag;Karim Raza;Lisa G M van Baarsen;Elisabeth Brouwer

  • Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

    Rogier M. Thurlings;Koen Vos;Carla A. Wijbrandts;Aeilko Zwinderman

  • Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation.

    Paul P. Tak;Paul P. Tak;Danielle M. Gerlag;Danielle M. Gerlag;Karl R. Aupperle;Deliana A. Van De Geest

  • Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial

    Clarissa E. Vergunst;Daniëlle M. Gerlag;Luba Lopatinskaya;L. Klareskog

  • A randomized controlled trial with an anti-CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

    Jasper J. Haringman;Danielle M. Gerlag;Tom J. M. Smeets;Dominique Baeten;Dominique Baeten

  • Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase

    M G H van de Sande;M J H de Hair;C van der Leij;P L Klarenbeek

  • Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis : the PRAIRI study

    Danielle M Gerlag;Mary Safy;Karen I Maijer;Man Wai Tang

  • Synovial tissue research: a state-of-the-art review

    Carl Orr;Elsa Sousa;David L Boyle;Maya H Buch

  • Smoking and overweight determine the likelihood of developing rheumatoid arthritis

    Maria J H de Hair;Robert B M Landewé;Marleen G H van de Sande;Dirkjan van Schaardenburg

  • Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.

    Koen Vos;Rogier M. Thurlings;Carla A. Wijbrandts;Dirkjan van Schaardenburg

  • Body mass index and clinical response to infliximab in rheumatoid arthritis.

    Ruth Klaasen;Carla A. Wijbrandts;Danielle M. Gerlag;Paul P. Tak

  • Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis

    M J H de Hair;M G H van de Sande;T H Ramwadhdoebe;M Hansson

  • MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis

    Ivy Y Choi;Danielle M Gerlag;Marieke J Herenius;Rogier M Thurlings

  • Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease

    P. L Klarenbeek;M. J. H de Hair;M. E Doorenspleet;B. D. C van Schaik

  • Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis

    Danielle M. Gerlag;Jasper J. Haringman;Tom J. M. Smeets;A. H. Zwinderman

  • Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation

    C. E. Vergunst;D. M. Gerlag;H. Dinant;L. Schulz

  • Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?

    Lisa G M van Baarsen;Maria C Lebre;Dennis van der Coelen;Saïda Aarrass

  • Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss

    C A Wijbrandts;R Klaasen;M G W Dijkgraaf;D M Gerlag

  • Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

    Rogier M. Thurlings;Marie Boumans;Janneke Tekstra;Joel A. van Roon

  • Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity

    M.E. Doorenspleet;P.L. Klarenbeek;M.J.H. de Hair;B.D.C. van Schaik

  • Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

    Solveig K. Sieberts;Fan Zhu;Javier García-García;Eli Stahl

Frequent Co-Authors

Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Dominique Baeten
Dominique Baeten University of Amsterdam
Frank Baas
Frank Baas Leiden University Medical Center
Douglas J. Veale
Douglas J. Veale University College Dublin
David L. Boyle
David L. Boyle University of California, San Diego
Ursula Fearon
Ursula Fearon Trinity College Dublin
Gary S. Firestein
Gary S. Firestein University of California, San Diego
Anca I. Catrina
Anca I. Catrina Karolinska University Hospital
Barry Bresnihan
Barry Bresnihan University College Dublin
Iain B. McInnes
Iain B. McInnes University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students consider advanced nursing roles that blend clinical expertise with specialized knowledge in patient care. For example, exploring the top online pmhnp programs is an excellent step for those aiming to become Psychiatric-Mental Health Nurse Practitioners, where understanding immunological factors in mental health is increasingly valued.

Cost is often a critical factor for prospective students. The cheapest online pmhnp programs provide accessible paths without sacrificing quality, making specialized nursing degrees attainable for more candidates.

Graduates pursuing these paths want to be informed of potential earnings. Checking the dnp salary by specialty helps in understanding the financial outlook for different nursing specializations aligned with immunology-related healthcare roles.

For nurses already certified as Family Nurse Practitioners, obtaining an acute care certification for fnp is a strategic move. This transition enhances skills for handling complex immunological cases in acute settings, broadening career prospects and clinical impact.

Best Scientists Citing Danielle M. Gerlag

Trending Scientists

Recently Published Articles